2Petersen Js,Karlsen AE, Markholst H,et al. Neonetal tolerization with glutamic acid decarboxylase but not with serum albumic delays the onset of diabetes in NOD mice. Diabetes, 1994;4:1478.
3Merrill J, Rowley M, Chen QY, et al. Antibodies to glutamic acid 4decarboxylase discriminate major types of diabetes mellitus [J].Diabetes, 1992;41:548.
4Schmidli RS,Colman PG,Bonifacio E,et al.High level of concordance between assays for glutamic acid decarboxylase antibodies[J].Diabetes,1995;44:636-40.
5Turner R,Stratton I,Horton V,et al.UKPDS 25 au-toantibodies to islet cell cytoplasm and glutamic acid de-carboxylase for prediction of insulin requirement in type 2 diabetes[J].Lancet,1997;350:1288-93.
6Kobayashi T,Nakanishi K,Murase Y,et al.Small doses ofsubcutaneous insulin as a strategy for preventing slowly progres-sive beta-cell failure in islet cell antibody-positive patients withclinical features of NIDDM[J]. Diabetes,1996;45:622-6.
7Kobayashi T,Mauyama T,Schimada A,et al.Insulin in-tervention to preserve beta cells in slowly progressive insu-lin-dependent (type 1) diabetes mellitus[J].Ann NY Acad Sci,2002;958:117-30.
